MAM
Hemant Tiwari appointed Hitachi Vantara GM for India biz
MUMBAI: Hitachi Vantara, a subsidiary of Hitachi Ltd has appointed Hemant Tiwari as the general manager for India business.
Tiwari will lead the Vantara business and operations in India with a focus on growing the overall business, accelerating the expansion of the company’s revenue, market share in India and building up the partner ecosystem.
He brings to Hitachi Vantara a vast experience driving the growth of data centre, hybrid cloud portfolio across consumer, enterprise server, storage and networking.
Commenting on his appointment, Hemant Tiwari says, “I am thrilled to be joining the Hitachi Vantara team, and I look forward to working closely with our partners and customers to take full advantage of the fast-growing technology landscape and opportunities that the Indian market has to offer. As the technology industry continues to evolve across different segments, it is truly an exciting time to lead and drive the company’s growth in India.”
Hitachi Vantara APAC senior vice president and general manager Daniel Chong adds, “India is a critical market for Hitachi Vantara. With the immense potential and digital-led transformation that the country is witnessing today, the business opportunities in creating an innovative data-driven approach for our customers to deliver business value and accelerate their digital transformation journey are phenomenal. We are excited about the leadership Hemant will provide in growing our business in the India market through our unique expertise and innovative technology solutions.”
Hemant Tiwari comes with an experience of over 35 years in IT industry. Prior to joining Hitachi, he worked with Hewlett Packard for over two decades at various senior management positions across India and Asia.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
